Strength Seen in Septerna, Inc. (SEPN): Can Its 7.0% Jump Turn into More Strength?Zacks Investment Research • 10/09/25
Septerna Appoints Veteran Biotechnology Leader Keith Gottesdiener, M.D., to its Board of DirectorsGlobeNewsWire • 09/29/25
Septerna Announces Dosing of the First Participants in Phase 1 Clinical Trial of SEP-631, an Oral Small Molecule MRGPRX2 Negative Allosteric Modulator for the Treatment of Mast Cell-Driven DiseasesGlobeNewsWire • 08/21/25
Septerna Highlights Business Progress and Reports Second Quarter 2025 Financial ResultsGlobeNewsWire • 08/11/25
Does Septerna, Inc. (SEPN) Have the Potential to Rally 151.27% as Wall Street Analysts Expect?Zacks Investment Research • 05/21/25
Septerna: Novo's Investment In Incretin Program Intrigues - One For The WatchlistSeeking Alpha • 05/16/25
Septerna: Deal With Novo Nordisk Is A Game Changer While It Still Trades Well Below Net CashSeeking Alpha • 05/16/25
Septerna Highlights Business Progress and Reports First Quarter 2025 Financial ResultsGlobeNewsWire • 05/15/25
Septerna Stock Surges on Oral Obesity Drug Deal With Novo NordiskZacks Investment Research • 05/15/25
Septerna stock pops on partnership with Novo Nordisk to develop obesity therapiesProactive Investors • 05/14/25
Novo Nordisk Inks $2.2 Billion Deal With Septerna To Develop Oral Weight Loss And Diabetes DrugsBenzinga • 05/14/25
Novo Nordisk Inks A Major Obesity Deal, Sending Shares Of New Partner Septerna SkyrocketingInvestors Business Daily • 05/14/25
Novo Nordisk strikes $2.2 billion deal with Septerna to develop new obesity treatmentsReuters • 05/14/25
Novo Nordisk A/S: Septerna and Novo Nordisk to collaborate on oral small molecule medicines for obesity and other cardiometabolic diseasesGlobeNewsWire • 05/14/25
Wall Street Analysts Predict a 207.31% Upside in Septerna, Inc. (SEPN): Here's What You Should KnowZacks Investment Research • 04/16/25
Septerna Provides Corporate Overview and Reports Fourth Quarter and Full Year 2024 Financial ResultsGlobeNewsWire • 03/27/25
SEPN Investors Have Opportunity to Join Septerna, Inc. Fraud Investigation with the Schall Law FirmPRNewsWire • 03/19/25
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Septerna, Inc. - SEPNAccesswire • 03/19/25
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Septerna, Inc. (SEPN) And Encourages Shareholders to Reach OutAccesswire • 03/06/25